On November 16, 2014, the 21st subject was enrolled in our ongoing study of MDMA-assisted psychotherapy for 24 U.S. veterans, firefighters, and police officers with treatment-resistant PTSD. A regularly scheduled site monitoring visit was also completed from November 13-16 by MAPS Clinical Research Associate Ben Shechet. Led by Principal Investigator Michael Mithoefer, M.D., and Annie Mithoefer, B.S.N., this Phase 2 pilot study is comparing three different doses of MDMA combined with psychotherapy for military veterans and first responders for whom other treatments have failed. “Soon after going through MDMA-assisted psychotherapy, I stopped taking all my prescription medications, which I had been taking (unsuccessfully) for my PTSD symptoms,” Iraq veteran and former study subject Tony Macie writes in his Winter 2014 MAPS Bulletin article. “This catapulted me into learning how to take care of myself without medications.” Dr. Mithoefer will be discussing ongoing research into MDMA-assisted psychotherapy for PTSD at the upcoming American Psychiatric Association Annual Meeting in Toronto, Canada, from May 16-20, 2015. Learn more…
